Super-flexible skin bonding biological glue and preparation process thereof

By using innovative processes such as high-energy electron beam radiation and cross-linking reactions in skin adhesives, skin bonding bioglues with ultra-flexible and high adhesion are prepared, solving the flexibility and adhesion of traditional adhesives. The problem of insufficient strength improves biocompatibility and wound healing ability, and is suitable for a variety of medical applications.

CN118924940APending Publication Date: 2024-11-12ZHEJIANG PERFECTSEAL NEW MATERIAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410975779.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Traditional skin adhesives have shortcomings in flexibility, adhesion, biocompatibility and ability to promote wound healing, especially when used in frequently-moving areas, with reduced comfort and poor healing.

Method used

By selecting polyethylene glycol with a molecular weight of 4000 to 6000 Da, it is used to perform high-energy electron beam radiation and grafting reaction, combined with Jingniping and Jingxi inhibitors for cross-linking, and melt processing and stretch cooling, and finally with α-cyanoacrylic acid Esters, polyethylene glycol of different molecular weights, collagen fibers and active agents are combined to prepare skin-adhesive bioglue with ultra-flexible and high adhesion.

Benefits of technology

The prepared bioglue has excellent flexibility and adhesion, good biocompatibility and ability to promote wound healing. It is suitable for medical bonding and wound healing, improving comfort and therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004954471050000081
    Figure BDA0004954471050000081
Patent Text Reader

Abstract

The invention discloses a preparation process of super-flexible skin bonding biological glue, which comprises the following steps: S1, radiating high molecular weight polyethylene glycol to generate free radicals, and adding a long-chain monomer containing carboxyl and an initiator for grafting reaction; s2, carrying out a cross-linking reaction on the modified starch and genipin under a proper condition; adding a crystal habit inhibitor, controlling the reaction temperature and the stirring rate, and continuing the cross-linking reaction for a certain time to obtain modified polyethylene glycol; s3, sequentially carrying out melting processing, stretching and rapid cooling operation, and controlling the crystallization behavior; and S4, compounding with alpha-cyanoacrylate, low-molecular-weight polyethylene glycol, medium-molecular-weight polyethylene glycol, collagen fibers, an active agent and an auxiliary agent to obtain the super-flexible skin bonding biological glue. The preparation process of the biological glue solves the problem of limitation of an existing skin adhesive in the aspects of flexibility, adhesive force, biocompatibility and wound healing promoting capacity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biological glue, in particular to super-flexible skin-adhesive biological glue and a preparation process thereof. Background Art

[0002] In the medical field, skin adhesives have been widely used in clinical practice as a fast and simple wound closure tool. Traditional skin adhesives are usually based on materials such as cyanoacrylate or polyisobutylene. Although they have certain bonding effects, they are insufficient in flexibility, adhesion, biocompatibility, and the ability to promote wound healing. These limitations limit the scope of application and effect of skin adhesives to a certain extent. In particular, the problem of insufficient flexibility is particularly evident in areas with frequent activities such as joints. The rigidity of the adhesive reduces patient comfort and may affect the healing effect due to adhesive breakage or tearing of the wound. In addition, low adhesion often requires additional sutures or other fixation methods when facing wounds with greater tension, which increases the complexity of treatment and patient discomfort.

[0003] In view of this, those skilled in the art have been seeking improvement solutions in order to develop skin adhesives with better flexibility, stronger adhesion, higher biocompatibility and the ability to promote wound healing. The present invention is proposed in this context, aiming to prepare a new type of skin adhesive biological glue through a series of innovative chemical and physical processing steps, in order to solve the limitations of existing adhesives and provide a better wound closure solution. Summary of the invention

[0004] In view of the above shortcomings of the prior art, the present invention provides a preparation process of an ultra-flexible skin adhesive biological glue to solve the limitations of existing skin adhesives in flexibility, adhesion, biocompatibility and the ability to promote wound healing. Through an innovative preparation process, a new type of skin adhesive biological glue with ultra-flexibility, high adhesion, good biocompatibility and the ability to effectively promote wound healing is provided.

[0005] In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0006] A preparation process of ultra-flexible skin adhesive biological glue, the preparation process comprising the following steps:

[0007] S1: Select polyethylene glycol with a molecular weight of 4000-6000Da as one of the basic colloids; irradiate with high-energy electron beam for several minutes to generate free radicals on the polyethylene glycol chain, then add long-chain monomers containing carboxyl groups and initiators, and carry out grafting reaction under ultraviolet light;

[0008] S2: mixing the polyethylene glycol grafted in step S1 with genipin under certain pH and temperature conditions for a pre-crosslinking reaction; after a certain reaction time, adding an appropriate amount of a crystal habit inhibitor, controlling a certain reaction temperature and stirring rate, and continuing the crosslinking reaction for a certain time to obtain a modified polyethylene glycol;

[0009] S3: subjecting the modified polyethylene glycol obtained in step S2 to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol;

[0010] S4: compounding the modified polyethylene glycol obtained in step S3 with α-cyanoacrylate, polyethylene glycol with a molecular weight of 500 to 2000 Da, polyethylene glycol with a molecular weight of 2000 to 4000 Da, collagen fiber, an active agent and an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue.

[0011] The present invention can prepare a skin adhesive biological glue with super flexibility through carefully designed chemical reactions and physical processing steps. First, step S1 selects polyethylene glycol with a molecular weight of 4000 to 6000 Da as one of the basic colloids. Polyethylene glycol in this molecular weight range has good fluidity and adhesion, providing an ideal starting material for the adhesive; the introduction of a long-chain monomer with a carboxyl group through a grafting reaction not only enhances the flexibility of polyethylene glycol, but also improves its adhesion to the skin surface. Secondly, in the pre-cross-linking stage, step S2 forms a preliminary three-dimensional network structure through a mixed reaction with genipin, and the addition of a crystal habit inhibitor effectively prevents excessive crystallization and maintains the softness and elasticity of the material. Again, step S3 includes physical processing steps such as melt processing, stretching and rapid cooling, which further finely regulates the crystallization morphology of the material, promotes the formation of microcrystalline or amorphous structures, and effectively improves the flexibility and adhesion of the biological glue.

[0012] The present invention conceives that the modified high molecular weight polyethylene glycol is rationally compounded with low molecular weight polyethylene glycol and medium molecular weight polyethylene glycol, which can not only improve the viscosity and fluidity of the biological glue, but also improve its cohesion and stability, and optimize its flexibility and ductility, thereby ensuring that the biological glue meets the high performance requirements of skin adhesion.

[0013] The addition of the collagen fiber of the present invention significantly improves the performance of the ultra-flexible skin adhesive biological glue. It has good biocompatibility and a three-dimensional network structure that is conducive to cell attachment and growth, which not only enhances the adhesion to the skin and promotes wound healing, but also improves the mechanical strength and toughness of the biological glue, making the biological glue safer and more effective, and suitable for medical bonding and wound healing.

[0014] As a preferred technical solution, the long-chain monomer containing a carboxyl group is at least one of pimelic acid, suberic acid, azelaic acid, and sebacic acid.

[0015] As a preferred technical solution, the initiator is at least one of dialkoxyacetophenone, α-hydroxyalkylphenone, and α-aminoalkylphenone.

[0016] As a preferred technical solution, the radiation dose of the high-energy electron beam is 20-50 kGy, and the radiation time is 5-10 min; the wavelength of the ultraviolet lamp is 365 nm, and the irradiation intensity is 0.5-1.5 W / cm 2 The irradiation time is 20 to 30 minutes.

[0017] As a preferred technical solution, the crystal habit inhibitor is composed of amino acids and polyoxyethylene alkylphenol ether (Triton X-100). The amino acid is glutamic acid or aspartic acid.

[0018] As a preferred technical solution, in step S2, the pH value of the pre-crosslinking reaction is 7.0-7.4, and the reaction temperature is 20-25°C; the reaction temperature of the continued crosslinking reaction is 30-37°C, and the stirring rate is 200-800rpm.

[0019] As a preferred technical solution, in step S3, the melt processing, stretching, and rapid cooling operations are: heating the modified polyethylene glycol to 10 to 20°C higher than the melting point, then stretching it in a temperature range slightly lower than the melting point but higher than the glass transition temperature, and finally rapidly cooling it to room temperature.

[0020] As a preferred technical solution, the α-cyanoacrylate is at least one of ethyl α-cyanoacrylate, methoxyethyl α-cyanoacrylate, n-butyl α-cyanoacrylate, n-octyl α-cyanoacrylate, and sec-octyl α-cyanoacrylate.

[0021] As a preferred technical solution, the active agent is composed of an antibacterial agent and epidermal growth factor EGF. The active agent of the present invention not only has antibacterial properties, but also has multiple effects of promoting healing and improving healing quality, making the biological glue prepared by the present invention an efficient and safe medical adhesive material.

[0022] As a preferred technical solution, the auxiliary agent is at least one of a plasticizer, a stabilizer, and an antioxidant.

[0023] Another aspect of the present invention is to provide a super-flexible skin-adhesive biological glue, wherein the biological glue is prepared by the above-mentioned preparation process of the super-flexible skin-adhesive biological glue, and the viscosity of the biological glue is 10,000 to 50,000 centipoise.

[0024] Beneficial effects of the present invention:

[0025] The preparation process of the ultra-flexible skin adhesive biological glue of the present invention, the modified polyethylene glycol obtained through steps S1 to S3, has a uniform three-dimensional network structure and amorphous or microcrystalline crystalline form, which gives the biological glue excellent flexibility and comfort while maintaining adhesion. At the same time, by compounding polyethylene glycols of different molecular weights, the present invention further optimizes the viscosity, fluidity, cohesion and stability of the biological glue, while enhancing flexibility and ductility. In addition, the added collagen fibers, active agents and additives further ensure that the biological glue has multiple functions such as antibacterial and wound healing, so that it meets the high-performance use requirements of skin adhesion.

[0026] In general, the present invention successfully prepared an ultra-flexible skin adhesive biological glue with excellent performance through a series of innovative chemical and physical processing steps. The bioglue has good biocompatibility and is an efficient, safe and multifunctional medical adhesive material with broad application prospects and commercial value. DETAILED DESCRIPTION

[0027] The following description is used to disclose the present invention so that those skilled in the art can implement the present invention. The preferred embodiments described below are only examples, and those skilled in the art may think of other obvious variations.

[0028] Example 1

[0029] The preparation process of the ultra-flexible skin adhesive biological glue of this embodiment comprises the following steps:

[0030] S1: 80g of polyethylene glycol with an average molecular weight of 4500Da was selected as one of the basic colloids; high-energy electron beam irradiation was performed for several minutes to generate free radicals on the polyethylene glycol chain, and then 12g of sebacic acid and 0.8g of α-aminoalkylphenone were added, and the grafting reaction was carried out under ultraviolet light irradiation; the radiation dose of the high-energy electron beam was 30kGy, and the irradiation time was 8min; the wavelength of the ultraviolet lamp was 365nm, and the irradiation intensity was 1.2W / cm 2 , the irradiation time is 25min.

[0031] S2: The polyethylene glycol grafted in step S1 is mixed with 35g of genipin under certain pH and temperature conditions for pre-crosslinking reaction; after reacting for 30 minutes, an appropriate amount of crystal habit inhibitor is added, and a certain reaction temperature and stirring rate are controlled. After the crosslinking reaction is continued for 2 hours, the modified polyethylene glycol is obtained; the pH value of the pre-crosslinking reaction is 7.2, and the reaction temperature is 25°C; the reaction temperature of the continued crosslinking reaction is 37°C, and the stirring rate is 500rpm. The crystal habit inhibitor is composed of 3g of glutamic acid and 1g of polyoxyethylene alkylphenol ether (Triton X-100).

[0032] S3: The modified polyethylene glycol obtained in step S2 is sequentially subjected to melt processing, stretching, and rapid cooling operations to control the crystallization behavior of the modified polyethylene glycol; the melt processing, stretching, and rapid cooling operations are: the modified polyethylene glycol is heated to 10°C above the melting point, and then stretched in a temperature range slightly below the melting point but above the glass transition temperature, the stretching rate is controlled to be 1.5 mm / s, the stretching ratio is 3, and finally rapidly cooled to room temperature. The melting point of the modified polyethylene glycol is determined to be 73°C using differential scanning calorimetry (DSC) during the experiment.

[0033] S4: 50 g of the modified polyethylene glycol obtained in step S3 is compounded with 120 g of ethyl α-cyanoacrylate, 24 g of polyethylene glycol with a molecular weight of 1500 Da, 16 g of polyethylene glycol with a molecular weight of 3500 Da, 6 g of collagen fiber, 1.5 g of an active agent and 3.8 g of an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue. The viscosity of the biological glue is 28400 centipoise.

[0034] The active agent consists of antibacterial agent chlorhexidine and epidermal growth factor EGF in a mass ratio of 9:1.

[0035] The auxiliary agent includes a plasticizer epoxidized soybean oil, a stabilizer vitamin C and an antioxidant beta-carotene in a mass ratio of 1:2:1.

[0036] Example 2

[0037] The preparation process of the ultra-flexible skin adhesive biological glue of this embodiment comprises the following steps:

[0038] S1: 80g of polyethylene glycol with an average molecular weight of 5000Da was selected as one of the basic colloids; high-energy electron beam irradiation was applied for several minutes to generate free radicals on the polyethylene glycol chain, and then 12g of azelaic acid and 0.8g of α-hydroxyalkyl phenone were added to carry out grafting reaction under ultraviolet light; the radiation dose of the high-energy electron beam was 20kGy, and the irradiation time was 10min; the wavelength of the ultraviolet lamp was 365nm, and the irradiation intensity was 1.5W / cm 2 , the irradiation time is 20min.

[0039] S2: The polyethylene glycol grafted in step S1 is mixed with 40g of genipin under certain pH and temperature conditions for pre-crosslinking reaction; after reacting for 30 minutes, an appropriate amount of crystal habit inhibitor is added, and a certain reaction temperature and stirring rate are controlled. After the crosslinking reaction is continued for 2.5 hours, the modified polyethylene glycol is obtained; the pH value of the pre-crosslinking reaction is 7.4, and the reaction temperature is 25°C; the reaction temperature of the continued crosslinking reaction is 30°C, and the stirring rate is 800rpm. The crystal habit inhibitor is composed of 3g of aspartic acid and 1g of polyoxyethylene alkylphenol ether (Triton X-100).

[0040] S3: The modified polyethylene glycol obtained in step S2 is subjected to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol; the melt processing, stretching, and rapid cooling operations are as follows: the modified polyethylene glycol is heated to 10° C. above the melting point, and then stretched in a temperature range slightly below the melting point but above the glass transition temperature, the stretching rate is controlled to be 1.5 mm / s, the stretching ratio is 3, and finally the modified polyethylene glycol is rapidly cooled to room temperature.

[0041] S4: 45 g of the modified polyethylene glycol obtained in step S3 is compounded with 120 g of n-butyl α-cyanoacrylate, 21 g of polyethylene glycol with a molecular weight of 800 Da, 14 g of polyethylene glycol with a molecular weight of 2700 Da, 5 g of collagen fiber, 1.2 g of an active agent and 3.6 g of an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue. The viscosity of the biological glue is 34600 centipoise.

[0042] The active agent and auxiliary agent are the same as those in Example 1.

[0043] Example 3

[0044] The preparation process of the ultra-flexible skin adhesive biological glue of this embodiment comprises the following steps:

[0045] S1: 80g of polyethylene glycol with an average molecular weight of 5500Da was selected as one of the basic colloids; high-energy electron beam irradiation was applied for several minutes to generate free radicals on the polyethylene glycol chain, and then 12g of suberic acid and 0.8g of dialkoxyacetophenone were added to carry out grafting reaction under ultraviolet light irradiation; the radiation dose of the high-energy electron beam was 40kGy, and the irradiation time was 5min; the wavelength of the ultraviolet lamp was 365nm, and the irradiation intensity was 0.5W / cm 2 , the irradiation time is 30min.

[0046] S2: The polyethylene glycol grafted in step S1 is mixed with 45g of genipin under certain pH and temperature conditions for pre-crosslinking reaction; after reacting for 25 minutes, an appropriate amount of crystal habit inhibitor is added, and a certain reaction temperature and stirring rate are controlled. After the crosslinking reaction is continued for 3 hours, the modified polyethylene glycol is obtained; the pH value of the pre-crosslinking reaction is 7.4, and the reaction temperature is 25°C; the reaction temperature of the continued crosslinking reaction is 37°C, and the stirring rate is 400rpm. The crystal habit inhibitor is composed of 3g of glutamic acid and 1g of polyoxyethylene alkylphenol ether (Triton X-100).

[0047] S3: The modified polyethylene glycol obtained in step S2 is subjected to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol; the melt processing, stretching, and rapid cooling operations are as follows: the modified polyethylene glycol is heated to 15° C. above the melting point, and then stretched in a temperature range slightly below the melting point but above the glass transition temperature, the stretching rate is controlled to be 1.5 mm / s, the stretching ratio is 3, and finally the modified polyethylene glycol is rapidly cooled to room temperature.

[0048] S4: 55 g of the modified polyethylene glycol obtained in step S3 is compounded with 120 g of n-octyl α-cyanoacrylate, 27 g of polyethylene glycol with a molecular weight of 1200 Da, 18 g of polyethylene glycol with a molecular weight of 2700 Da, 9 g of collagen fiber, 1.5 g of an active agent and 4.1 g of an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue. The viscosity of the biological glue is 42100 centipoise.

[0049] The active agent and auxiliary agent are the same as those in Example 1.

[0050] Example 4

[0051] The preparation process of the ultra-flexible skin adhesive biological glue of this embodiment comprises the following steps:

[0052] S1: 80g of polyethylene glycol with an average molecular weight of 4500Da was selected as one of the basic colloids; high-energy electron beam irradiation was performed for several minutes to generate free radicals on the polyethylene glycol chain, and then 12g of pimelic acid and 0.8g of α-aminoalkylphenone were added, and the grafting reaction was carried out under ultraviolet light irradiation; the radiation dose of the high-energy electron beam was 50kGy, and the irradiation time was 5min; the wavelength of the ultraviolet lamp was 365nm, and the irradiation intensity was 0.5W / cm 2 , the irradiation time is 30min.

[0053] S2: The polyethylene glycol grafted in step S1 is mixed with 35g of genipin under certain pH and temperature conditions for pre-crosslinking reaction; after reacting for 35 minutes, an appropriate amount of crystal habit inhibitor is added, and a certain reaction temperature and stirring rate are controlled. After the crosslinking reaction is continued for 2 hours, the modified polyethylene glycol is obtained; the pH value of the pre-crosslinking reaction is 7.4, and the reaction temperature is 25°C; the reaction temperature of the continued crosslinking reaction is 37°C, and the stirring rate is 600rpm. The crystal habit inhibitor is composed of 3g of aspartic acid and 1g of polyoxyethylene alkylphenol ether (Triton X-100).

[0054] S3: The modified polyethylene glycol obtained in step S2 is subjected to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol; the melt processing, stretching, and rapid cooling operations are as follows: the modified polyethylene glycol is heated to 15° C. above the melting point, and then stretched in a temperature range slightly below the melting point but above the glass transition temperature, the stretching rate is controlled to be 1.5 mm / s, the stretching ratio is 3, and finally the modified polyethylene glycol is rapidly cooled to room temperature.

[0055] S4: 50g of the modified polyethylene glycol obtained in step S3 is compounded with 135g of α-octyl cyanoacrylate, 24g of polyethylene glycol with a molecular weight of 500Da, 16g of polyethylene glycol with a molecular weight of 3000Da, 6g of collagen fiber, 1.5g of active agent and 3.8g of auxiliary agent to obtain the ultra-flexible skin adhesive biological glue. The viscosity of the biological glue is 21700 centipoise.

[0056] The active agent and auxiliary agent are the same as those in Example 1.

[0057] Example 5

[0058] The preparation process of the ultra-flexible skin adhesive biological glue of this embodiment comprises the following steps:

[0059] S1: 80g of polyethylene glycol with an average molecular weight of 4500Da was selected as one of the basic colloids; high-energy electron beam irradiation was performed for several minutes to generate free radicals on the polyethylene glycol chain, and then 12g of sebacic acid and 0.8g of α-hydroxyalkyl phenone were added, and the grafting reaction was carried out under ultraviolet light irradiation; the radiation dose of the high-energy electron beam was 25kGy, and the irradiation time was 10min; the wavelength of the ultraviolet lamp was 365nm, and the irradiation intensity was 1.0W / cm 2 , the irradiation time is 25min.

[0060] S2: The polyethylene glycol grafted in step S1 is mixed with 35g of genipin under certain pH and temperature conditions for pre-crosslinking reaction; after reacting for 30 minutes, an appropriate amount of crystal habit inhibitor is added, and a certain reaction temperature and stirring rate are controlled. After the crosslinking reaction is continued for 3 hours, the modified polyethylene glycol is obtained; the pH value of the pre-crosslinking reaction is 7.2, and the reaction temperature is 25°C; the reaction temperature of the continued crosslinking reaction is 35°C, and the stirring rate is 2800rpm. The crystal habit inhibitor is composed of 3g of glutamic acid and 1g of polyoxyethylene alkylphenol ether (Triton X-100).

[0061] S3: The modified polyethylene glycol obtained in step S2 is subjected to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol; the melt processing, stretching, and rapid cooling operations are as follows: the modified polyethylene glycol is heated to 10° C. above the melting point, and then stretched in a temperature range slightly below the melting point but above the glass transition temperature, the stretching rate is controlled to be 1.5 mm / s, the stretching ratio is 3, and finally the modified polyethylene glycol is rapidly cooled to room temperature.

[0062] S4: 50 g of the modified polyethylene glycol obtained in step S3 is compounded with 150 g of α-methoxyethyl cyanoacrylate, 24 g of polyethylene glycol with a molecular weight of 1000 Da, 16 g of polyethylene glycol with a molecular weight of 3300 Da, 6 g of collagen fiber, 1.5 g of an active agent and 3.8 g of an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue. The viscosity of the biological glue is 24500 centipoise.

[0063] The active agent and auxiliary agent are the same as those in Example 1.

[0064] The skin adhesive biological glue prepared in Examples 1 to 5 was subjected to performance tests, and the performance results are shown in Table 1:

[0065] Among them, the adhesion test method: use a tensile strength tester to perform adhesion strength test to simulate the tensile force under skin adhesion conditions.

[0066] Flexibility test method: When the sample is subjected to a tensile test, the elongation at break of the bioglue is measured when it is stretched.

[0067] Biocompatibility test method: Skin irritation test is carried out according to ISO 10993 standard, and the evaluation is carried out by observing the skin's reaction to the test material.

[0068] Wound healing test method: Wound healing test was performed on animal models, and the wound closure speed and healing quality were evaluated after 7 days. The wound healing speed was measured by the reduction rate of wound area.

[0069] Antibacterial test method: The agar diffusion method was used for testing, specifically: first, Staphylococcus aureus was selected as the test bacteria, and then these bacteria were cultured on nutrient agar medium to the logarithmic growth phase; second, the bioglue sample was diluted in an appropriate solvent, and then filled into the holes of the solidified agar plate, and then inverted and cultured at 37°C; finally, after 24 hours of culture, the bacterial growth was observed, and the diameter of the inhibition zone formed around the antibacterial agent hole was measured to reflect the antibacterial effect of the bioglue.

[0070] Stability test method: The bioglue was stored for 90 days under different environmental conditions (high temperature 40°C, low temperature -10°C, 90% relative humidity and 30% relative humidity for 20 days, 10 days, 20 days and 40 days respectively), and then the average change rate of its adhesion and flexibility was tested to evaluate the stability of the bioglue. Table 1

[0071] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments, and the above embodiments and descriptions only describe the principles of the present invention. The present invention may be subject to various changes and improvements without departing from the spirit and scope of the present invention, and these changes and improvements fall within the scope of the present invention claimed.

Claims

1. A preparation process of ultra-flexible skin adhesive biological glue, It is characterized in that The preparation process comprises the following steps: S1: Select polyethylene glycol with a molecular weight of 4000-6000Da as one of the basic colloids; irradiate with high-energy electron beam for several minutes to generate free radicals on the polyethylene glycol chain, then add long-chain monomers containing carboxyl groups and initiators, and carry out grafting reaction under ultraviolet light; S2: mixing the polyethylene glycol grafted in step S1 with genipin under certain pH and temperature conditions for a pre-crosslinking reaction; after a certain reaction time, adding an appropriate amount of a crystal habit inhibitor, controlling a certain reaction temperature and stirring rate, and continuing the crosslinking reaction for a certain time to obtain a modified polyethylene glycol; S3: subjecting the modified polyethylene glycol obtained in step S2 to melt processing, stretching, and rapid cooling operations in sequence to control the crystallization behavior of the modified polyethylene glycol; S4: compounding the modified polyethylene glycol obtained in step S3 with α-cyanoacrylate, polyethylene glycol with a molecular weight of 500 to 2000 Da, polyethylene glycol with a molecular weight of 2000 to 4000 Da, collagen fiber, an active agent and an auxiliary agent to obtain the ultra-flexible skin adhesive biological glue.

2. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The long-chain monomer containing a carboxyl group is at least one of pimelic acid, suberic acid, azelaic acid and sebacic acid.

3. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The radiation dose of the high-energy electron beam is 20-50 kGy, and the radiation time is 5-10 min; the wavelength of the ultraviolet lamp is 365 nm, and the irradiation intensity is 0.5-1.5 W / cm 2 The irradiation time is 20 to 30 minutes.

4. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The crystal habit inhibitor is composed of amino acids and polyoxyethylene alkylphenol ether.

5. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that In step S2, the pH value of the pre-crosslinking reaction is 7.0-7.4, and the reaction temperature is 20-25°C; the reaction temperature of the continued crosslinking reaction is 30-37°C, and the stirring rate is 200-800 rpm.

6. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that In step S3, the melt processing, stretching, and rapid cooling operations are as follows: the modified polyethylene glycol is heated to 10-20° C. above the melting point, then stretched within a temperature range slightly below the melting point but above the glass transition temperature, and finally rapidly cooled to room temperature.

7. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The α-cyanoacrylate is at least one of ethyl α-cyanoacrylate, methoxyethyl α-cyanoacrylate, n-butyl α-cyanoacrylate, n-octyl α-cyanoacrylate, and sec-octyl α-cyanoacrylate.

8. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The active agent consists of the antibacterial agent chlorhexidine and epidermal growth factor EGF.

9. The preparation process of the ultra-flexible skin adhesive biological glue as claimed in claim 1, It is characterized in that The auxiliary agent is at least one of a plasticizer, a stabilizer and an antioxidant.

10. A super flexible skin bonding biological glue, It is characterized in that The biological glue is prepared by the preparation process of the ultra-flexible skin adhesive biological glue according to any one of claims 1 to 9, and the viscosity of the biological glue is 10,000 to 50,000 centipoise.